Therefore, these data strongly support our hypothesis that low immunogenic stimulation with tumor antigens (eg, TAAs) leads to sustained expression of CD27 and CD28 in tumor-specific CD8+ T cells and promotes their differentiation into DP Temra over DN Temra. The gene discussed is CD28; the disease is neoplasm.